tiprankstipranks
Sumitomo Chemical Co Ltd (SOMMF)
OTHER OTC:SOMMF
US Market
Want to see SOMMF full AI Analyst Report?

Sumitomo Chemical Co (SOMMF) Earnings Dates, Call Summary & Reports

5 Followers

Earnings Data

Report Date
Jul 31, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.09
Last Year’s EPS
-0.02
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Feb 03, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented materially stronger profitability and earnings momentum (notably a large YoY increase in core operating income and net income, improved D/E and an increased dividend), driven by Sumitomo Pharma performance and gains/divestitures in Essential & Green Materials. However, these positives are tempered by a significant YoY decline in sales revenue, deterioration in free cash flow versus prior year, expected concentrated nonrecurring losses in Q4 (impairments/restructuring), segment weakness (ICT & Mobility) and ongoing commodity and regional headwinds. On balance, the improvements in core profitability, upgraded guidance and balance sheet metrics outweigh the lowlights, though risks remain for Q4 and commodity‑sensitive businesses.
Company Guidance
Management nudged FY2025 guidance higher: sales are forecast at ¥2.3 trillion (up ¥10 billion vs the November plan), core operating income ¥200 billion (up ¥15 billion vs November), and net income attributable to owners ¥55 billion (up ¥1.5 billion vs November; up ¥10 billion year‑on‑year). Management said recurring profit excluding divestment gains improved from ~¥80 billion last year to ~¥120 billion this year, lifted ICT & Mobility guidance by ¥2 billion, increased others/company‑wide expenses by ¥13 billion, and warned that non‑recurring losses will be concentrated in Q4. The year‑end dividend was raised to ¥7.5 (annual ¥13.5, +¥4.5 vs prior year; payout ratio ≈40%). Assumptions cited include an illustrative Q3 USD/JPY ~148.71 and naphtha ~¥65,000/kl.
Sharp Increase in Core Operating Income
Core operating income for Q3 was JPY 186.8 billion, up JPY 126.8 billion year‑on‑year — an increase of approximately 211% — driven by improvements across Sumitomo Pharma and Essential & Green Materials and gains on business divestitures.
Strong Net Income Attributable to Owners
Net income attributable to owners for Q3 was JPY 87.4 billion, up JPY 58.8 billion year‑on‑year (≈+206%), exceeding the November forecast for the quarter.
Sumitomo Pharma Outperformance
Sumitomo Pharma reported core operating income of JPY 111.2 billion, up JPY 86.9 billion YoY (≈+358%), supported by increased sales of Orgovyx and Gemtesa and gains from partial transfer/divestiture of its Asian business.
Essential & Green Materials Turnaround (Including Rabigh Gain)
Essential & Green Materials core operating income improved to JPY 19.8 billion, a YoY improvement of JPY 64.1 billion, reflecting a gain on the partial sale of Petro Rabigh shares, improved refining margins and lower naphtha feedstock costs.
Balance Sheet Improvement and Increased Dividend
Interest‑bearing debt fell to JPY 1.2215 trillion (down JPY 64.6 billion YoY); D/E ratio improved from 1.20x to 0.96x (improvement of 0.23x). Management raised the year‑end dividend from JPY 6 to JPY 7.5 per share (annual dividend JPY 13.5, up JPY 4.5 from prior year) with an expected payout ratio of ~40%.
Upgraded Full‑Year Guidance
Full‑year core operating income forecast was raised to JPY 200 billion (up JPY 15 billion vs November guidance). Sales forecast at JPY 2.3 trillion (up JPY 10 billion vs prior guidance). Net income attributable to owners forecast JPY 55 billion (up JPY 1.5 billion vs November guidance; cited as up JPY 10 billion YoY in presentation).
Operating Cash Flow and Positive Free Cash Flow
Operating cash flow remained positive at JPY 111.6 billion and free cash flow was positive JPY 71.8 billion for the quarter, maintaining liquidity despite year‑on‑year deterioration.

Sumitomo Chemical Co (SOMMF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SOMMF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 31, 2026
2026 (Q1)
0.09 / -
-0.017
May 14, 2026
2025 (Q4)
-0.12 / -0.10
0.039-365.03% (-0.14)
Feb 03, 2026
2025 (Q3)
-0.01 / 0.18
0.13535.69% (+0.05)
Nov 04, 2025
2025 (Q2)
0.15 / 0.17
-0.119242.96% (+0.29)
Aug 01, 2025
2025 (Q1)
>-0.01 / -0.02
0.094-118.51% (-0.11)
May 14, 2025
2024 (Q4)
0.11 / 0.04
-0.779104.95% (+0.82)
Feb 03, 2025
2024 (Q3)
0.09 / 0.14
-0.129204.99% (+0.26)
Oct 30, 2024
2024 (Q2)
-0.17 / -0.12
-0.16728.46% (+0.05)
Aug 02, 2024
2024 (Q1)
-0.05 / 0.09
-0.128173.56% (+0.22)
May 15, 2024
2023 (Q4)
-0.86 / -0.78
-0.206-278.78% (-0.57)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SOMMF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2026
$3.23$3.230.00%
Feb 03, 2026
$2.76$2.760.00%
Nov 04, 2025
$2.71$2.710.00%
Aug 01, 2025
$2.67$2.670.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sumitomo Chemical Co Ltd (SOMMF) report earnings?
Sumitomo Chemical Co Ltd (SOMMF) is schdueled to report earning on Jul 31, 2026, TBA (Confirmed).
    What is Sumitomo Chemical Co Ltd (SOMMF) earnings time?
    Sumitomo Chemical Co Ltd (SOMMF) earnings time is at Jul 31, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SOMMF EPS forecast?
          SOMMF EPS forecast for the fiscal quarter 2026 (Q1) is 0.09.